Sector revisions BeiGene, Ltd.

Equities

BGNE

US07725L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 14/09/2024 am IST 5-day change 1st Jan Change
198.49 USD +1.13% Intraday chart for BeiGene, Ltd. +3.75% +10.05%
Main competitors
Add to a list
1m. EPS revision 1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Divergence of Estimates Nbr of analysts
21
29
25
15
18
17
18
- - - 7
16
25
19
7
19
- - - -
10
21
- 13
4
21
Average 17
Weighted average by Cap. 22
Bio Therapeutic Drugs
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW